β-(1→3),(1→6)-Glucans: medicinal activities, characterization, biosynthesis and new horizons (2015)
Fonte: Applied Microbiology and Biotechnology. Unidade: FCFRP
Assuntos: BIOLOGIA MOLECULAR, BIOTECNOLOGIA, FUNGOS, ANTIFÚNGICOS, POLISSACARÍDEOS, BASIDIOMYCOTA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DALONSO, Nicole e GOLDMAN, Gustavo Henrique e GERN, Regina Maria Miranda. β-(1→3),(1→6)-Glucans: medicinal activities, characterization, biosynthesis and new horizons. Applied Microbiology and Biotechnology, v. 99, n. 19, p. 7893-7906, 2015Tradução . . Disponível em: https://doi.org/10.1007/s00253-015-6849-x. Acesso em: 15 nov. 2025.APA
Dalonso, N., Goldman, G. H., & Gern, R. M. M. (2015). β-(1→3),(1→6)-Glucans: medicinal activities, characterization, biosynthesis and new horizons. Applied Microbiology and Biotechnology, 99( 19), 7893-7906. doi:10.1007/s00253-015-6849-xNLM
Dalonso N, Goldman GH, Gern RMM. β-(1→3),(1→6)-Glucans: medicinal activities, characterization, biosynthesis and new horizons [Internet]. Applied Microbiology and Biotechnology. 2015 ; 99( 19): 7893-7906.[citado 2025 nov. 15 ] Available from: https://doi.org/10.1007/s00253-015-6849-xVancouver
Dalonso N, Goldman GH, Gern RMM. β-(1→3),(1→6)-Glucans: medicinal activities, characterization, biosynthesis and new horizons [Internet]. Applied Microbiology and Biotechnology. 2015 ; 99( 19): 7893-7906.[citado 2025 nov. 15 ] Available from: https://doi.org/10.1007/s00253-015-6849-x
